Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
about
Functional interactions among members of the MAX and MLX transcriptional network during oncogenesisExpression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformationExpression and clinical significance of HCCS1 in non-small cell lung cancer.Analysis of the Max-binding protein MNT in human medulloblastomas.Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer.
P2860
Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
@en
Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
@nl
type
label
Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
@en
Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
@nl
prefLabel
Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
@en
Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
@nl
P2093
P2860
P1476
Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.1998.TB00569.X
P577
1998-04-01T00:00:00Z